We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$135B
AUM Growth
+$18.8B
Cap. Flow
+$813M
Cap. Flow %
0.6%
Top 10 Hldgs %
18.56%
Holding
2,870
New
103
Increased
1,731
Reduced
679
Closed
79

Sector Composition

Rank Sector Weight
1 Technology 18.21%
2 Healthcare 13.78%
3 Financials 13.47%
4 Consumer Discretionary 12.16%
5 Communication Services 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSF icon
2226
AMERISAFE
AMSF
$540M
$345K ﹤0.01%
5,800
+1,665
+40% +$98.9K
CARB
2227
DELISTED
Carbonite Inc
CARB
$341K ﹤0.01%
13,732
-1,866
-12% -$48K
PAHC icon
2228
Phibro Animal Health
PAHC
$1.39B
$340K ﹤0.01%
10,292
+1,134
+12% +$35.3K
GRC icon
2229
Gorman-Rupp
GRC
$2.21B
$339K ﹤0.01%
9,980
OMER icon
2230
Omeros
OMER
$959M
$339K ﹤0.01%
19,500
-9,300
-32% -$134K
EGRX
2231
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$338K ﹤0.01%
6,701
+1,401
+26% +$62.3K
ANIP icon
2232
ANI Pharmaceuticals
ANIP
$1.78B
$338K ﹤0.01%
4,790
+3,948
+469% +$232K
NCMI icon
2233
National CineMedia
NCMI
$378M
$336K ﹤0.01%
4,768
+252
+6% +$18.1K
QTNA
2234
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
$336K ﹤0.01%
13,810
-4,790
-26% -$83.4K
MODN
2235
DELISTED
MODEL N, INC.
MODN
$335K ﹤0.01%
19,111
+1,500
+9% +$24K
VNDA icon
2236
Vanda Pharmaceuticals
VNDA
$302M
$334K ﹤0.01%
18,156
+4,732
+35% +$108K
QUAD icon
2237
Quad
QUAD
$525M
$334K ﹤0.01%
28,055
+1,100
+4% +$14.8K
VIG icon
2238
Vanguard Dividend Appreciation ETF
VIG
$114B
$334K ﹤0.01%
3,043
-103
-3% -$10.9K
PLUG icon
2239
Plug Power
PLUG
$3.04B
$333K ﹤0.01%
138,920
MSTR icon
2240
Strategy Inc
MSTR
$38.4B
$333K ﹤0.01%
23,100
+380
+2% +$5.26K
MOD icon
2241
Modine Manufacturing
MOD
$10.4B
$333K ﹤0.01%
24,012
+2,114
+10% +$29.7K
FF icon
2242
Future Fuel
FF
$223M
$333K ﹤0.01%
24,844
SKY icon
2243
Champion Homes
SKY
$5.14B
$333K ﹤0.01%
17,500
+5,200
+42% +$95.3K
PRTA icon
2244
Prothena Corp
PRTA
$450M
$331K ﹤0.01%
27,320
+12,320
+82% +$154K
CIA icon
2245
Citizens
CIA
$192M
$331K ﹤0.01%
49,602
+1,100
+2% +$7.85K
PAM icon
2246
Pampa Energía
PAM
$4.41B
$331K ﹤0.01%
12,000
+4,300
+56% +$144K
LMNX
2247
DELISTED
Luminex Corp
LMNX
$330K ﹤0.01%
14,351
-5,477
-28% -$138K
AXDX
2248
DELISTED
Accelerate Diagnostics
AXDX
$330K ﹤0.01%
1,570
LABL
2249
DELISTED
Multi-Color Corp
LABL
$329K ﹤0.01%
6,600
+300
+5% +$14K
FPH icon
2250
Five Point Holdings
FPH
$375M
$329K ﹤0.01%
45,581
+12,637
+38% +$95.1K

Similar funds

UBS AM's Q1 2019 Portfolio in Review

As of Q1 2019, UBS AM held 2,870 positions worth $135B, up 16% from $116B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

UBS AM's Q1 2019 filing shows 103 new, 1,731 increased, 679 reduced and 79 closed positions. Its largest new stake was Fox Class A: 1,047,931 shares worth $38.5M. The largest sale was PepsiCo, an estimated $224M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • UBS AM's largest Q1 2019 buy was Fox Class A: 1,047,931 shares worth $38.5M.
  • UBS AM added most to Procter & Gamble in Q1 2019, an estimated $257M increase.
  • UBS AM's biggest Q1 2019 reduction was PepsiCo, cutting an estimated $224M.
  • UBS AM fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $156M.
  • UBS AM's ten largest holdings make up 19% of its $135B portfolio in Q1 2019.
  • UBS AM opened 103 new positions and closed 79 in Q1 2019.
  • UBS AM's portfolio value rose 16% quarter-over-quarter to $135B.

Based on UBS AM's 13F filing for Q1 2019, filed 14 May 2019.